Developer docs
API playgroundTry for free, no card

Search company profiles

Atlantic Healthcare

Full company profile

uuid000353j

Namestring
Atlantic Healthcare
Legal namestring
Atlantic Healthcare
Websiteurl
atlantichc.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Atlantic Healthcare operates the TOKYO77 online gambling and sports betting platform, marketed under the alternative trade name TUNASBOLA, and accessible via the atlantichc.com web domain and an Android APK mobile application. The platform aggregates content from more than 30 game providers including Pragmatic Play, PG Soft, Microgaming, Playtech, Habanero, Spade Gaming, Jili, Hacksaw Gaming, Joker, and FastSpin, covering slots, sports betting, live casino, crash games, arcade, poker, e-sports, sabung ayam (cockfighting), togel (lottery), and virtual racing. It is operated from Manila, Philippines, is described as licensed by PAGCOR, and targets consumers in Indonesia and Southeast Asia with 14+ language support and integrations to Indonesian local payment rails (BCA, BNI, BRI, Mandiri, Danamon, Nobu, Permata, DANA, OVO, and QR).

The platform generates revenue on a transactional basis through the house edge on wagers across slots, sportsbook margins, live casino, and other gambling products, and runs a tiered loyalty program (Bronze through Diamond) with weekly cashback, rolling commissions, and tournament-based prize pools. Separately, firmographic records describe Atlantic Healthcare as a UK-based (Saffron Walden) rare-disease pharmaceutical company founded in 2006, specializing in gastroenterology, with 11–50 employees and a leadership team (CEO Toby Wilson Waterworth, VP Manufacturing Mike Webb, Director of Clinical Development Chris Dunk). Funding history indicates approximately $63.3M raised across eight rounds from 2006 through 2019, with investors including Ionis Pharmaceuticals, Salix Pharmaceuticals, LDC, Fullbrook Thorpe Investments, The FSE Group, HM Treasury, and EndoLogic USA. The relationship between the historical pharmaceutical entity and the current TOKYO77 gambling operations is not clarified in available sources.

Short descriptiontext

Atlantic Healthcare operates the TOKYO77 online gambling and sports betting platform, aggregating 30+ game providers across slots, sportsbook, live casino, and lottery for consumers in Indonesia and Southeast Asia, while firmographic records also describe a UK rare-disease gastroenterology pharmaceutical entity.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaffron Walden, United Kingdom
HQ citystring
Saffron Walden
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease therapeutics, gastroenterology pharmaceuticals, specialty biopharmaceuticals, orphan drug development, clinical-stage therapeutics
Industry2 codes
1Gastroenterology Specialty Pharmaceuticals
CodeHLAIACAEPrimaryYes
2Gastroenterology & Hepatology Pharmaceuticals
CodeHLAIAAAIPrimaryNo
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Gastroenterology Therapeutics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Gambling Transaction Revenue
TypeTransaction Fee
Description

Revenue generated from house edge on casino games, sportsbook margins, and slot machine payouts. Platform takes a percentage of each wager placed across slots, sports betting, live casino, and other gambling products.

atlantichc.com
2Promotional Bonus Rolling
TypeTransaction Fee
Description

Weekly cashback (Rollingan Casino 0.5%), cashback on arcade (5% minimum Rp 25,000), and sportsbook cashback (5%) plus commission (0.5%) distributed weekly on Tuesdays.

atlantichc.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Atlantic Healthcare is a UK-based specialty pharmaceutical company that acquires, develops, and commercializes therapeutics, with a particular focus on rare diseases in the gastroenterology therapeutic area. The company operates a full-lifecycle model spanning in-licensing/acquisition, clinical development, in-house manufacturing, and commercialization of its therapeutic portfolio to healthcare providers serving rare gastroenterology patients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

TOKYO77 is an online gambling and sports betting platform offering a comprehensive portfolio of gaming products. The platform operates on a multi-provider model featuring Slots (via Pragmatic Play, PG Soft, Jili, Hacksaw, MicroGaming, Playtech, and many others), Sportsbook (Saba Sportsbook, SBO Sportsbook, BTi Gaming), Live Casino (ION Casino, PP Casino, MG Live, Evo Gaming), Crash Games (Aviator, Gemini), Arcade, Poker, E-Sports, Sabung Ayam (cockfight betting), Togel (lottery), and Race. The platform also includes a loyalty program with tiered levels and various promotional bonuses including welcome bonuses, cashback, and rolling commissions. A mobile Android APK app is available for on-the-go access.

Product and service1 record
1Rare Disease Gastroenterology Therapeutic Portfolio
CategoryGastroenterology Therapeutics
Description

Therapeutics acquired, developed, in-house manufactured, and commercialized by Atlantic Healthcare for rare gastroenterological conditions. The portfolio is served via an institutional B2B pharmaceutical distribution model targeting hospitals, specialty clinics, and gastroenterology departments rather than direct-to-patient channels.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeTechnology or Integration
Description

Primary slot game provider offering popular titles like Gates of Olympus, Sweet Bonanza, and Mahjong Wins. Provides Gacor Festival tournaments with millions in prize pools.

Strategic tierCoreTypeTechnology or Integration
Description

Mobile-focused slot provider offering games like Mahjong Ways, Lucky Neko, and Wild Bandito. Provides exclusive tournaments and 8% daily deposit bonus promotions.

Strategic tierCoreTypeTechnology or Integration
Description

Leading casino game developer since 1994, based in Isle of Man with 700+ games portfolio. Provides MG Live casino and slot tournaments including 'Jalan Menuju Kejayaan' with billions in prizes.

Strategic tierCoreTypeTechnology or Integration
Description

Slot and gaming provider offering games like Fortune Gems 500 and FORTUNE GARUDA 500. Provides Daily Gacor Wins tournaments.

Strategic tierCoreTypeTechnology or Integration
Description

Provider of slot and crash games including popular titles. Hosts Victory Unleashed World Cup Tournament with prize pools.

6Saba Sportsbook
Strategic tierCoreTypeTechnology or Integration
Description

Sports betting platform with high stability, elasticity, and security. Offers 100+ football leagues with 5,000+ matches and 18,000 markets per month.

atlantichc.com
Strategic tierCoreTypeTechnology or Integration
Description

Sportsbook provider offering best odds in Asia, extra parlay bonuses, unlimited free bets, and exclusive gamification promotions.

Strategic tierMajorTypeTechnology or Integration
Description

Global gaming technology provider. Hosts 'Pesta Hujan Uang' (Money Rain Party) promotion with 300 million IDR prize pool combining leaderboard and cash drop mechanics.

Strategic tierMajorTypeTechnology or Integration
Description

Slot provider offering games like Koi Gate and Hot Hot Nexus. Hosts World Cup Edition Champion tournaments.

Strategic tierMajorTypeTechnology or Integration
Description

Asian-focused slot provider. Hosts 'Half Year Hustle Eksklusif' with Fortune Wheel and Red Packet Progressive mechanics.

Strategic tierMajorTypeTechnology or Integration
Description

Slot provider hosting Joker Royal Arena competitions with 943 prizes worth IDR 140 million weekly.

Strategic tierMajorTypeTechnology or Integration
Description

Slot provider hosting 'Tantangan Gol Global' and 'Balapan Untuk Sang Juara' tournaments with experience point progression systems.

Strategic tierMajorTypeTechnology or Integration
Description

Provider hosting FIFA 2026 themed promotions with betting challenges, match day spins, and cash rain events.

Strategic tierMajorTypeTechnology or Integration
Description

Slot provider partnered with Pragmatic Play for exclusive VIP Player Tournaments.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1AbbVie
TypeBroad incumbent
Description

Global pharma with a major gastroenterology franchise (Humira/Skyrizi/Rinvoq in IBD via the Allergan acquisition). Comparable as a broad incumbent with leading GI assets.

TypeEmerging player
Description

Clinical-stage biopharma developing precision therapeutics for immune-mediated GI diseases (IBD). Comparable as a smaller, GI-focused developer operating in the same therapeutic adjacency.

TypeDirect peer
Description

GI specialty pharma (Xifaxan, Relistor) now part of Bausch Health. Directly comparable to Atlantic Healthcare on gastroenterology focus, and was itself a repeat investor in the company, making it both a peer and a strategic counterparty.

TypeDirect peer
Description

GI specialty pharma behind Linzess (linaclotide). Comparable in GI therapeutic focus, small commercial-stage footprint and US/EU commercialisation model.

TypeBroad incumbent
Description

Global pharma with a substantial gastroenterology franchise (Entyvio for IBD). Comparable as a broad incumbent operating in the same therapeutic category with overlapping patient populations.

TypeBroad incumbent
Description

Large specialty pharma holding company whose Salix division is the leading US gastroenterology franchise. Comparable as a broader incumbent in the same GI therapeutic category Atlantic Healthcare targets.

TypeDirect peer
Description

Specialty biopharma with a gastrointestinal programme (Yumeglon Gelsolin) and broader small-cap therapeutics pipeline. Comparable on specialty pharma positioning and GI therapeutic development.

TypeDirect peer
Description

Specialty biopharma developing first-in-class GI/renal therapies (tenapanor/Ibsrela). Comparable as a small-cap, late-development GI therapeutics company.

TypeDirect peer
Description

Specialty pharma focused on gastrointestinal diseases (Talicia, Aemcolo, movantik). Comparable as a small-cap GI-focused therapeutics developer and commercialiser.

TypeDirect peer
Description

Rare-disease biopharma with Bylvay (odevixibat) for rare paediatric cholestatic liver disease. Comparable on rare-disease, GI/liver therapeutic focus and commercial-stage execution.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Atlantic Healthcare

Gastroenterology Therapeuticsatlantichc.com

Atlantic Healthcare operates the TOKYO77 online gambling and sports betting platform, aggregating 30+ game providers across slots, sportsbook, live casino, and lottery for consumers in Indonesia and Southeast Asia, while firmographic records also describe a UK rare-disease gastroenterology pharmaceutical entity.

What Atlantic Healthcare does

Atlantic Healthcare operates the TOKYO77 online gambling and sports betting platform, marketed under the alternative trade name TUNASBOLA, and accessible via the atlantichc.com web domain and an Android APK mobile application. The platform aggregates content from more than 30 game providers including Pragmatic Play, PG Soft, Microgaming, Playtech, Habanero, Spade Gaming, Jili, Hacksaw Gaming, Joker, and FastSpin, covering slots, sports betting, live casino, crash games, arcade, poker, e-sports, sabung ayam (cockfighting), togel (lottery), and virtual racing. It is operated from Manila, Philippines, is described as licensed by PAGCOR, and targets consumers in Indonesia and Southeast Asia with 14+ language support and integrations to Indonesian local payment rails (BCA, BNI, BRI, Mandiri, Danamon, Nobu, Permata, DANA, OVO, and QR).

The platform generates revenue on a transactional basis through the house edge on wagers across slots, sportsbook margins, live casino, and other gambling products, and runs a tiered loyalty program (Bronze through Diamond) with weekly cashback, rolling commissions, and tournament-based prize pools. Separately, firmographic records describe Atlantic Healthcare as a UK-based (Saffron Walden) rare-disease pharmaceutical company founded in 2006, specializing in gastroenterology, with 11–50 employees and a leadership team (CEO Toby Wilson Waterworth, VP Manufacturing Mike Webb, Director of Clinical Development Chris Dunk). Funding history indicates approximately $63.3M raised across eight rounds from 2006 through 2019, with investors including Ionis Pharmaceuticals, Salix Pharmaceuticals, LDC, Fullbrook Thorpe Investments, The FSE Group, HM Treasury, and EndoLogic USA. The relationship between the historical pharmaceutical entity and the current TOKYO77 gambling operations is not clarified in available sources.

Atlantic Healthcare firmographics

Firmographics
Name
Atlantic Healthcare
Legal name
Atlantic Healthcare
Website
https://atlantichc.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Atlantic Healthcare operates the TOKYO77 online gambling and sports betting platform, aggregating 30+ game providers across slots, sportsbook, live casino, and lottery for consumers in Indonesia and Southeast Asia, while firmographic records also describe a UK rare-disease gastroenterology pharmaceutical entity.
Ownership category
akta.pro rank

Atlantic Healthcare industry classification

Industry
Product category
Gastroenterology Therapeutics
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Gastroenterology Specialty Pharmaceuticals (HLAIACAE)
akta.pro secondary industry
Gastroenterology & Hepatology Pharmaceuticals (HLAIAAAI)

Keywords

  • Rare disease therapeutics
  • Gastroenterology pharmaceuticals
  • Specialty biopharmaceuticals
  • Orphan drug development
  • Clinical-stage therapeutics

Where Atlantic Healthcare is headquartered

Location

Headquarters

HQ city
Saffron Walden
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Atlantic Healthcare business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Gambling Transaction Revenue: Revenue generated from house edge on casino games, sportsbook margins, and slot machine payouts. Platform takes a percentage of each wager placed across slots, sports betting, live casino, and other gambling products.
  2. Promotional Bonus Rolling: Weekly cashback (Rollingan Casino 0.5%), cashback on arcade (5% minimum Rp 25,000), and sportsbook cashback (5%) plus commission (0.5%) distributed weekly on Tuesdays.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Atlantic Healthcare product offering

Product offering

Core offering

Atlantic Healthcare is a UK-based specialty pharmaceutical company that acquires, develops, and commercializes therapeutics, with a particular focus on rare diseases in the gastroenterology therapeutic area. The company operates a full-lifecycle model spanning in-licensing/acquisition, clinical development, in-house manufacturing, and commercialization of its therapeutic portfolio to healthcare providers serving rare gastroenterology patients.

Product overview

TOKYO77 is an online gambling and sports betting platform offering a comprehensive portfolio of gaming products. The platform operates on a multi-provider model featuring Slots (via Pragmatic Play, PG Soft, Jili, Hacksaw, MicroGaming, Playtech, and many others), Sportsbook (Saba Sportsbook, SBO Sportsbook, BTi Gaming), Live Casino (ION Casino, PP Casino, MG Live, Evo Gaming), Crash Games (Aviator, Gemini), Arcade, Poker, E-Sports, Sabung Ayam (cockfight betting), Togel (lottery), and Race. The platform also includes a loyalty program with tiered levels and various promotional bonuses including welcome bonuses, cashback, and rolling commissions. A mobile Android APK app is available for on-the-go access.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rare Disease Gastroenterology Therapeutic Portfolio Therapeutics acquired, developed, in-house manufactured, and commercialized by Atlantic Healthcare for rare gastroenterological conditions. The portfolio is served via an institutional B2B pharmaceutical distribution model targeting hospitals, specialty clinics, and gastroenterology departments rather than direct-to-patient channels.

Companies that use Atlantic Healthcare

Customer profile

Segments1 record

Ideal customer profiles1 record

Atlantic Healthcare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Atlantic Healthcare partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and major.

  • Pragmatic PlaycoreTechnology or IntegrationPrimary slot game provider offering popular titles like Gates of Olympus, Sweet Bonanza, and Mahjong Wins. Provides Gacor Festival tournaments with millions in prize pools.
  • PG SoftcoreTechnology or IntegrationMobile-focused slot provider offering games like Mahjong Ways, Lucky Neko, and Wild Bandito. Provides exclusive tournaments and 8% daily deposit bonus promotions.
  • MicrogamingcoreTechnology or IntegrationLeading casino game developer since 1994, based in Isle of Man with 700+ games portfolio. Provides MG Live casino and slot tournaments including 'Jalan Menuju Kejayaan' with billions in prizes.
  • JilicoreTechnology or IntegrationSlot and gaming provider offering games like Fortune Gems 500 and FORTUNE GARUDA 500. Provides Daily Gacor Wins tournaments.
  • Hacksaw GamingcoreTechnology or IntegrationProvider of slot and crash games including popular titles. Hosts Victory Unleashed World Cup Tournament with prize pools.
  • Saba SportsbookcoreTechnology or IntegrationSports betting platform with high stability, elasticity, and security. Offers 100+ football leagues with 5,000+ matches and 18,000 markets per month.
  • BTi GamingcoreTechnology or IntegrationSportsbook provider offering best odds in Asia, extra parlay bonuses, unlimited free bets, and exclusive gamification promotions.
  • PlaytechmajorTechnology or IntegrationGlobal gaming technology provider. Hosts 'Pesta Hujan Uang' (Money Rain Party) promotion with 300 million IDR prize pool combining leaderboard and cash drop mechanics.
  • HabaneromajorTechnology or IntegrationSlot provider offering games like Koi Gate and Hot Hot Nexus. Hosts World Cup Edition Champion tournaments.
  • Spade GamingmajorTechnology or IntegrationAsian-focused slot provider. Hosts 'Half Year Hustle Eksklusif' with Fortune Wheel and Red Packet Progressive mechanics.
  • JokermajorTechnology or IntegrationSlot provider hosting Joker Royal Arena competitions with 943 prizes worth IDR 140 million weekly.
  • Fast SpinmajorTechnology or IntegrationSlot provider hosting 'Tantangan Gol Global' and 'Balapan Untuk Sang Juara' tournaments with experience point progression systems.
  • AdvantPlaymajorTechnology or IntegrationProvider hosting FIFA 2026 themed promotions with betting challenges, match day spins, and cash rain events.
  • Slot88majorTechnology or IntegrationSlot provider partnered with Pragmatic Play for exclusive VIP Player Tournaments.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Atlantic Healthcare competitors and assessment

Company assessment

Broad incumbents

  • AbbVie: Global pharma with a major gastroenterology franchise (Humira/Skyrizi/Rinvoq in IBD via the Allergan acquisition). Comparable as a broad incumbent with leading GI assets.
  • Takeda Pharmaceutical: Global pharma with a substantial gastroenterology franchise (Entyvio for IBD). Comparable as a broad incumbent operating in the same therapeutic category with overlapping patient populations.
  • Bausch Health: Large specialty pharma holding company whose Salix division is the leading US gastroenterology franchise. Comparable as a broader incumbent in the same GI therapeutic category Atlantic Healthcare targets.

Emerging players

  • Prometheus Biosciences: Clinical-stage biopharma developing precision therapeutics for immune-mediated GI diseases (IBD). Comparable as a smaller, GI-focused developer operating in the same therapeutic adjacency.

Direct peers

  • Salix Pharmaceuticals: GI specialty pharma (Xifaxan, Relistor) now part of Bausch Health. Directly comparable to Atlantic Healthcare on gastroenterology focus, and was itself a repeat investor in the company, making it both a peer and a strategic counterparty.
  • Ironwood Pharmaceuticals: GI specialty pharma behind Linzess (linaclotide). Comparable in GI therapeutic focus, small commercial-stage footprint and US/EU commercialisation model.
  • Theravance Biopharma: Specialty biopharma with a gastrointestinal programme (Yumeglon Gelsolin) and broader small-cap therapeutics pipeline. Comparable on specialty pharma positioning and GI therapeutic development.
  • Ardelyx: Specialty biopharma developing first-in-class GI/renal therapies (tenapanor/Ibsrela). Comparable as a small-cap, late-development GI therapeutics company.
  • RedHill Biopharma: Specialty pharma focused on gastrointestinal diseases (Talicia, Aemcolo, movantik). Comparable as a small-cap GI-focused therapeutics developer and commercialiser.
  • Albireo Pharma: Rare-disease biopharma with Bylvay (odevixibat) for rare paediatric cholestatic liver disease. Comparable on rare-disease, GI/liver therapeutic focus and commercial-stage execution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Atlantic Healthcare social profiles

Digital presence

Atlantic Healthcare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Atlantic Healthcare leadership team

Management profile

Number of profiles

Profiles3 records

Atlantic Healthcare funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Atlantic Healthcare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlantic Healthcare

What does Atlantic Healthcare do?

Atlantic Healthcare is a UK-based specialty pharmaceutical company that acquires, develops, and commercializes therapeutics, with a particular focus on rare diseases in the gastroenterology therapeutic area. The company operates a full-lifecycle model spanning in-licensing/acquisition, clinical development, in-house manufacturing, and commercialization of its therapeutic portfolio to healthcare providers serving rare gastroenterology patients.

Is Atlantic Healthcare a public or private company?

Atlantic Healthcare is a private company. It is classified as venture growth investor backed and is currently operating.

When was Atlantic Healthcare founded?

Atlantic Healthcare was founded in 2006. It employs 11 to 50 people.

Where is Atlantic Healthcare based?

Atlantic Healthcare is headquartered in Saffron Walden, United Kingdom, in the Europe region.

How does Atlantic Healthcare make money?

Two revenue lines are on record. Gambling Transaction Revenue is the primary driver. The others are promotional Bonus Rolling.

Who are Atlantic Healthcare's main competitors?

Broad incumbents on record are AbbVie, Takeda Pharmaceutical and Bausch Health. Prometheus Biosciences is listed as an emerging player. Direct peers are Salix Pharmaceuticals, Ironwood Pharmaceuticals, Theravance Biopharma, Ardelyx, RedHill Biopharma and Albireo Pharma.

Does Atlantic Healthcare have an API?

No public API is recorded for Atlantic Healthcare.

What industry is Atlantic Healthcare in?

Atlantic Healthcare's product category is Gastroenterology Therapeutics. Its primary akta.pro industry code is HLAIACAE, Gastroenterology Specialty Pharmaceuticals, with a secondary code of HLAIAAAI, Gastroenterology & Hepatology Pharmaceuticals. Its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireAtlantic Healthcare Appoints Finance Industry Veteran Andrew Jones to Board of DirectorsAtlantic Healthcare appointed Andrew Jones as non-executive director, bringing over 25 years of capital market experience. Thomas Wellner, long-time chairman, will retire, with Andrew Boyce serving as interim chairman. The company focuses on gastroenterology therapeutics, including alicaforsen and renzapride.GlobeNewswireAtlantic Healthcare to Present at the Biotech ShowcaseAtlantic Healthcare will present at the Biotech Showcase conference in San Francisco on January 14, 2020. The company owns exclusive rights to alicaforsen and renzapride, targeting GI diseases, with Phase 2 and Phase 3 ready programmes. It plans to commercialize in Europe and the U.S. using a specialist sales team.GlobeNewswireAtlantic Healthcare Reports Results from Phase 1 Trial of Tablet for CrohnsAtlantic Healthcare reported that its Phase 1 trial of an oral alicaforsen tablet for Crohn's disease found the formulation safe and well-tolerated. The trial involved 15 healthy male volunteers receiving 240mg alicaforsen, with all tablets disintegrating before the end of the small intestine and minimal systemic absorption. The company will now plan a Phase 2b efficacy trial.GlobeNewswireAtlantic Healthcare completes patient enrollment to itsAtlantic Healthcare completed enrollment in its Phase 3 study of alicaforsen enema for pouchitis, a rare IBD condition with no approved therapy. The randomized, double-blind, placebo-controlled trial at 40 centers across the U.S., Canada, Europe, and Israel is expected to report preliminary results in Q1 2019.GlobeNewswireAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisAtlantic Healthcare is developing two tablet formulations of alicaforsen for Crohn's disease and ulcerative colitis, with Phase 1 trials planned to confirm safety and release profiles. The UC formulation targets the terminal ileum, while the Crohn's formulation targets the small intestine. The company plans to commercialize the product in the U.S. and Europe.GlobeNewswireAtlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indicationAtlantic Healthcare appointed William Ringo and Andrew Boyce as non-executive directors and Thomas Wellner as permanent chairman, as it prepares to commercialize alicaforsen. The drug is in a pivotal Phase 3 trial for pouchitis, with a rolling FDA submission and plans for U.S. and European commercialization.